Books
Public Health Perspective on Intellectual Property and Access to Medicines
A compilation of studies prepared for WHO
South Centre, Geneva, 2016
Author: Carlos M. Correa
A compilation of studies prepared for WHO
South Centre, Geneva, 2016
Author: Carlos M. Correa
The WHO “Red Book” on Access to Medicines and Intellectual Property – 20 Years Later
South Centre, Geneva, 2015
Authors: Germán Velásquez & Pascale Boulet
South Centre, Geneva, 2015
Authors: Germán Velásquez & Pascale Boulet
Some Critical Issues Related to Access to Medicines and Intellectual Property
South Centre, Geneva, 2014
Author: Germán Velásquez
South Centre, Geneva, 2014
Author: Germán Velásquez
Policy Briefs
USMCA debe ser enmendado para asegurar el acceso a medicamentos en México
Informe Sobre Políticas 64, Agosto de 2019
Maria Fabiana Jorge
Informe Sobre Políticas 64, Agosto de 2019
Maria Fabiana Jorge
The US-Mexico-Canada Agreement: Putting Profits Before Patients
Policy Brief 61, May 2019
Maria Fabiana Jorge
Policy Brief 61, May 2019
Maria Fabiana Jorge
The ‘obvious to try’ method of addressing strategic patenting: How developing countries can utilise patent law to facilitate access to medicines
Policy Brief 59, April 2019
Olga Gurgula
Policy Brief 59, April 2019
Olga Gurgula
Research Papers
Antivirales de acción directa para la Hepatitis C: evolución de los criterios de patentabilidad y su impacto en la salud pública en Colombia
Documento de Investigación 96, Agosto de 2019
Francisco A. Rossi B. y Claudia M. Vargas P.
Documento de Investigación 96, Agosto de 2019
Francisco A. Rossi B. y Claudia M. Vargas P.
Access to Medicines: Experiences with Compulsory Licenses and Government Use – The case of Hepatitis C
Research Paper 85, April 2019
Carlos M. Correa and Germán Velásquez
Research Paper 85, April 2019
Carlos M. Correa and Germán Velásquez
Compulsory Licensing Jurisprudence in South Africa: Do We Have Our Priorities Right?
Research Paper 90, December 2018
Yousuf A Vawda
Research Paper 90, December 2018
Yousuf A Vawda